Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share (VRDN)

Q: What does CUSIP 92790C104 represent in this 13F holders report?

CUSIP 92790C104 is the security identifier for VRDN - Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share used to aggregate holder disclosures.

Q: How many institutions held VRDN - Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share in Q2 2026?

7 institutional investors reported VRDN - Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share for Q2 2026. Use the holders table for investor-level position and value details.

CUSIP: 92790C104

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / Common Stock, $0.01 par value per share
Total 13F shares: 292,249
Total 13F value: $5,377,097
Share change: +53,983
SEC-reported price per share: $18.37
Number of holders: 7
Value change: +$925,466
Number of buys: 5
Number of sells: 3
Shares outstanding: 110,466,431

Security key

92790C104

Report period

Q2 2026

Institutions

Top holders

VRDN full security history Ownership snapshot Full 13F holder table Previous quarter: Q1 2026 Viridian Therapeutics, Inc.\DE SEC filings Viridian Therapeutics, Inc.\DE company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 92790C104

Previous quarter: Q1 2026

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Ownership snapshot

Top reported holders of VRDN - Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Fairmount Funds Managemen...

Disclosed value leader

FMR LLC

Comparable rows

15/15

Latest evidence

18 Jun 2026

13D/G 3/4/5 13F Lead comparable stake: 14% 13D/G row: Fairmount Funds Management LLC Showing 1-6 of 15 holder rows.

Quick read

Fairmount Funds Management LLC leads the comparable SEC ownership view at 14%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Fairmount Funds Management LLC's linked filing trail.

Comparable ownership Top 5

Fairmount Funds Management LLC 14%

Bellevue Group AG 6.6%

Deep Track Capital, LP 5.3%

Paradigm Biocapital Advisors LP 5.1%

Venrock Healthcare Capital Partne... 4.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Fairmount Funds Management LLC	13D/G 3/4/5 13F Director, 10%+ Owner · Company 13D/G 3/4/5 13F	14%	$239,105,020 17,201,800 shares	+$16,352,933	11 May 2026
Bellevue Group AG	13F 13D/G Company 13F 13D/G	6.6% from 13D/G	$131,563,376 6,726,144 shares	—	31 Mar 2026
Deep Track Capital, LP	13D/G 13F Company 13D/G 13F	5.3%	$75,305,474 5,417,660 shares	+$40,210,295	01 May 2026
Paradigm Biocapital Advisors LP	13D/G 13F Company 13D/G 13F	5.1%	$99,323,682 5,633,788 shares	$0	18 Jun 2026
Venrock Healthcare Capital Partners III, L.P.	13D/G 13D/G	4.5%	$48,373,931 3,575,309 shares	$0	31 Dec 2024
Commodore Capital LP	13D/G 13D/G	3.9%	$69,056,000 3,200,000 shares	-$23,738,000	30 Sep 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

292,249

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders

223

Q2 2026 holders

Holder diff

-216

Investor	Q1 2026 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend